NL301087I2 - Recombinant Marek's disease virus (MDV), omvattende een lange terminale herhalingssequentie van een reticuloendotheliosevirus, waarbij de MDV-stam RN1250 is - Google Patents

Recombinant Marek's disease virus (MDV), omvattende een lange terminale herhalingssequentie van een reticuloendotheliosevirus, waarbij de MDV-stam RN1250 is

Info

Publication number
NL301087I2
NL301087I2 NL301087C NL301087C NL301087I2 NL 301087 I2 NL301087 I2 NL 301087I2 NL 301087 C NL301087 C NL 301087C NL 301087 C NL301087 C NL 301087C NL 301087 I2 NL301087 I2 NL 301087I2
Authority
NL
Netherlands
Prior art keywords
mdv
virus
terminal repeat
repeat sequence
long terminal
Prior art date
Application number
NL301087C
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Animal Health Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc
Publication of NL301087I2 publication Critical patent/NL301087I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL301087C 2012-03-22 2021-01-12 Recombinant Marek's disease virus (MDV), omvattende een lange terminale herhalingssequentie van een reticuloendotheliosevirus, waarbij de MDV-stam RN1250 is NL301087I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261614142P 2012-03-22 2012-03-22
PCT/US2013/032539 WO2013142377A2 (en) 2012-03-22 2013-03-15 Modified marek's disease virus, and vaccines made therefrom

Publications (1)

Publication Number Publication Date
NL301087I2 true NL301087I2 (nl) 2022-03-11

Family

ID=48045766

Family Applications (1)

Application Number Title Priority Date Filing Date
NL301087C NL301087I2 (nl) 2012-03-22 2021-01-12 Recombinant Marek's disease virus (MDV), omvattende een lange terminale herhalingssequentie van een reticuloendotheliosevirus, waarbij de MDV-stam RN1250 is

Country Status (28)

Country Link
US (3) US20130251737A1 (nl)
EP (2) EP3326646A1 (nl)
JP (1) JP2015512396A (nl)
KR (5) KR20230145532A (nl)
CN (1) CN104602706A (nl)
AP (1) AP2014007955A0 (nl)
AR (1) AR090472A1 (nl)
BR (1) BR112014023398A8 (nl)
CA (1) CA2868099C (nl)
CR (1) CR20140432A (nl)
DO (1) DOP2014000215A (nl)
EA (1) EA030866B1 (nl)
EC (1) ECSP14023407A (nl)
ES (1) ES2663610T3 (nl)
GE (1) GEP201706650B (nl)
GT (1) GT201400199A (nl)
HK (1) HK1255682A1 (nl)
IL (1) IL234721B (nl)
MA (1) MA37432A1 (nl)
MX (1) MX355332B (nl)
MY (1) MY169061A (nl)
NL (1) NL301087I2 (nl)
PE (1) PE20150323A1 (nl)
PH (1) PH12014502085B1 (nl)
TN (1) TN2014000393A1 (nl)
UA (1) UA117345C2 (nl)
WO (1) WO2013142377A2 (nl)
ZA (1) ZA201406884B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014023398A8 (pt) * 2012-03-22 2022-08-16 Merial Ltd Vírus da doença de marek modidicado e vacinas feitas do mesmo
CN106397602B (zh) * 2016-08-02 2019-06-18 青岛明勤生物科技有限公司 一种分子佐剂加强型鸡马立克氏病蛋白工程疫苗

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642574A (en) 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US4160024A (en) 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
NL8401120A (nl) 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
US4895717A (en) 1987-07-10 1990-01-23 The United States Of America As Represented By The Secretary Of Agriculture Revertant serotype 1 Marek's disease vaccine
US4895718A (en) 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
CZ299473B6 (cs) 1997-06-30 2008-08-06 Rhone-Poulenc Rorer S. A. Nukleová kyselina a elektrické pole jako sdruženýprodukt pro prenos nukleové kyseliny do bunek prícne pruhovaného svalstva
US20050019348A1 (en) * 2003-07-21 2005-01-27 Reddy Sanjay M. Marek's disease virus vaccine
BR112014023398A8 (pt) * 2012-03-22 2022-08-16 Merial Ltd Vírus da doença de marek modidicado e vacinas feitas do mesmo
US9113301B1 (en) 2014-06-13 2015-08-18 Snapchat, Inc. Geo-location based event gallery

Also Published As

Publication number Publication date
MX355332B (es) 2018-04-16
CR20140432A (es) 2015-01-09
MX2014011388A (es) 2014-10-14
ECSP14023407A (es) 2015-06-30
US11510978B2 (en) 2022-11-29
EP2827898B1 (en) 2017-12-20
KR20230028595A (ko) 2023-02-28
US20190216920A1 (en) 2019-07-18
KR102586316B1 (ko) 2023-10-06
PE20150323A1 (es) 2015-03-05
CN104602706A (zh) 2015-05-06
AP2014007955A0 (en) 2014-09-30
EP2827898A2 (en) 2015-01-28
UA117345C2 (uk) 2018-07-25
AR090472A1 (es) 2014-11-12
MA37432A1 (fr) 2016-03-31
BR112014023398A2 (pt) 2017-07-11
CA2868099A1 (en) 2013-09-26
WO2013142377A3 (en) 2014-01-23
KR20230145532A (ko) 2023-10-17
KR20220008945A (ko) 2022-01-21
CA2868099C (en) 2020-12-15
EA201401044A1 (ru) 2015-01-30
US20130251737A1 (en) 2013-09-26
DOP2014000215A (es) 2015-04-15
IL234721B (en) 2018-05-31
GT201400199A (es) 2018-10-15
TN2014000393A1 (en) 2015-12-21
EA030866B1 (ru) 2018-10-31
KR20140146136A (ko) 2014-12-24
PH12014502085A1 (en) 2014-11-24
US20230310589A1 (en) 2023-10-05
JP2015512396A (ja) 2015-04-27
ZA201406884B (en) 2015-11-25
ES2663610T3 (es) 2018-04-16
GEP201706650B (en) 2017-03-27
HK1255682A1 (zh) 2019-08-23
EP3326646A1 (en) 2018-05-30
KR20190100431A (ko) 2019-08-28
BR112014023398A8 (pt) 2022-08-16
MY169061A (en) 2019-02-12
KR102503316B1 (ko) 2023-02-23
PH12014502085B1 (en) 2014-11-24
WO2013142377A2 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
AU2016202543A1 (en) Human immunodeficiency virus (hiv)-neutralizing antibodies
EP3324979A4 (en) VACCINES AGAINST INFECTION DISEASES
ZA201602227B (en) Recombinant marek's disease viruses and uses thereof
EP3057592A4 (en) Hepatitis b viral assembly effectors
WO2015052543A3 (en) Malaria vaccination
BR112012030950A2 (pt) formulações de vacina
WO2014052378A8 (en) Subunit immersion vaccines for fish
EP2631290A4 (en) VIRUS VECTOR FOR PRIME-BOOST VACCINES WITH VACCINIAVIRUS VECTORS AND SENDAIVIRUS VECTORS
EP2519266A4 (en) INFECTIOUS DNA VACCINES AGAINST CHIKUNGUNYA VIRUS
NL301087I2 (nl) Recombinant Marek's disease virus (MDV), omvattende een lange terminale herhalingssequentie van een reticuloendotheliosevirus, waarbij de MDV-stam RN1250 is
EP2970942A4 (en) Polysialic acid, blood group antigens and glycoprotein expression
EP2940134A4 (en) USING THE HUMAN PARAIN FLUENZAVIRUS TYPE 2 VEGETABLE VACCINE
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
BR112013012815A2 (pt) solução aquosa de ambroxol
HK1210475A1 (en) Herpes simplex virus vaccine
PL2992005T3 (pl) Zmutowane białko wypustek rozszerzające tropizm tkankowy wirusa zakaźnego zapalenia oskrzeli (IBV)
WO2014008475A3 (en) Compositions and methods related to viral vaccines
BR112014028758A2 (pt) circuito elétrico, e, uso de um circuito elétrico.
BR112013013166A2 (pt) tratamentos da infecção pelo vírus da hepatite c
IT1400339B1 (it) Paratia terminale per banco di stesa per vibrofinitrice stradale.
ES1072508Y (es) Vado peatonal ceramico inteligente
Ovsyannikov et al. RAZRABOTKA STRUKTUR SKhEM ZARYaDNYKh USTROYSTV MODEL'NOGO RYaDA
Shcheblykin et al. ZAGOVOR PROTIV ROSSIYSKOY IMPERII-MIF ILI REAL'NOST'?
Stupakova et al. VSYaKIY SLYShIT TO, ChTO PONIMAET
Moiseeva et al. LEChEBNO-PROFILAKTIChESKIE MEROPRIYaTIYa DLYa PREDUPREZhDENIYa KARIOZNOGO PROTsESSA TVERDYKh TKANEY ZUBA